Center of Excellence in Higher Education
The First Private University in Bangladesh

Dr. Reatul Karim

Full Time Faculty
Assistant Professor

PhD in Biomedical and Pharmaceutical Sciences, University of Liege, Belgium 
PhD in Experimental and Clinical Pharmacology, University of Angers, France (Erasmus Mundus Joint Doctorate)
MRes in Drug Delivery Systems, University of Strathclyde, Glasgow, United Kingdom

Phone: +880-2-55668200 Ext: 6272 
Email: reatul.karim@northsouth.edu
Office:  

Curriculum Vitae

 

Dr. Reatul Karim is currently serving as an Assistant Professor in the Department of Pharmaceutical Sciences at North South University, Dhaka. He has a robust academic and reseach foundation that includes a Doctorate in Biomedical and Pharmaceutical Sciences from the University of Liège (Belgium) and Doctorate in Experimental and Clinical Pharmacology from the University of Angers (France) (via the prestigious NanoFar Erasmus Mundus Joint Doctorate program), and Masters by Research in Drug Delivery Systems from the University of Strathclyde, Glasgow (UK). Dr. Karim brings extensive academic experience to this role, having previously held faculty positions in several renowned universities in Bangladesh. In addition to his academic roles, he also has industrial experience from his tenure at Novartis Bangladesh Ltd., where he specialized in pharmaceutical process validation.

Dr. Karim has extensive expertise in nanomedicine and targeted drug delivery systems. His research has primarily focused on the design and evaluation of nanocarriers for the treatment of cancer and other challenging medical conditions. He also performs research in the field of public health. His research is widely recognized, with numerous publications in high-impact, Scopus-indexed journals and active participation in international conferences. His work spans topics such as the functionalization of lipid nanocapsules, tumor-targeted drug delivery, the pharmacological effects of natural compounds, and public health. He has secured several competitive research grants, including the Erasmus Mundus Fellowship, Fonds Léon Fredericq Grant, and support from the NSU CTRG and pharmaceutical companies like Beximco and Nuvista Pharma. He is also an active member of various professional and alumni organizations, contributing to both national and international scientific communities.

Journal Publications & Book Chapters

  1. Sarker, M., Chowdhury, N., Bristy, A. T., Emran, T., Karim, R., Ahmed, R., Shaki, M.M., Sharkar, S.M., Rahman, G.S. & Reza, H. M. (2024). Astaxanthin protects fludrocortisone acetate-induced cardiac injury by attenuating oxidative stress, fibrosis, and inflammation through TGF-β/Smad signaling pathway. Biomedicine & Pharmacotherapy, 181, 117703. [Scopus indexed, Q1]
  2. Bhowmik, L., Hasan, M. K., Bristy, T. A., Etu, S. T., Karim, R., Mostaid, M. S., Shill, M.C., & Reza, H. M. (2024). A Comparison of COVID-19 and post-COVID-19 Syndrome Among Symptomatic and Asymptomatic Patients in Bangladesh: A Retrospective Cohort Study. Heliyon, e36202. [Scopus indexed, Q1]
  3. Karim, R., Khan, S. I., Bari, R., Akash, M. A., Chowdhury, A. K., Seum, M. A. A., Yousuf, K.N., & Reza, H. M. (2024). Factors affecting stress and depression in Bangladeshi students: a cross-sectional study. Asian Journal of Social Health and Behavior, 7(2), 84-93. [Scopus indexed, Q1]
  4. Khan, S. I., Karim, R., Khan, S. I., Chowdhury, M. A. K., Shill, M. C., Pasha, F. M., Shohag, M. H., Khan, F., Islam, M. A., Mitul, A. I., Ahmad, R., Hossain, M. S., & Reza, H. M. (2024). Factors affecting severity and prognosis of traumatic brain injury among Bangladeshi patients: An institution based cross-sectional study. Traffic Injury Prevention, 1–9. Advanced online publication. [Scopus indexed, Q1]
  5. Kuddus, S.A., Alam, A., Sifat, A.M., Tamanna, T., Alam, S., Abedin, F., Karim, R., Sultan, M.Z., Khan, F. (2023). Effect of polymer concentration on the release of naproxen from enteric coated sustained release tablets. Journal of Biosciences and Experimental Pharmacology, 1, 70-90.
  6. Shahrin, A., Akter, C., Khan, S.I., & Karim, R. (2022). Bioactive compounds of turmeric and their pharmacological effects. Journal of Multidisciplinary Sciences, 4(2), 1-9.
  7. Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Eyer, J., Piel, G., & Passirani, C. (2018). Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide. Nanoscale, 10(28), 13485-13501. [Scopus indexed, Q1]
  8. Karim, , Palazzo, C., Laloy, J., Delvigne, A.S., Vanslambrouck, S., Jerome, C., Lepeltier, E., Orange, F., Dogne, J.M., Evrard, B., Passirani, C. (2017). Development and evaluation of injectable nanosized drug delivery systems for apigenin. International Journal of Pharmaceutics. 532(2), 757-768. [Scopus indexed, Q1]
  9. Karim, R., Somani, , Al Robaian, M., Mullin, M., Amor, R., McConnell, G., Dufès, C. (2017). Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. Journal of Controlled Release, 246, 79-87. [Scopus indexed, Q1]
  10. Palazzo, , Karim, R., Evrard, B., Piel, G. (2016). Drug delivery nanocarriers to cross of the blood-brain barrier. Nanobiomaterials in drug delivery. (Book Chapter, Publisher: Elsevier Inc.)
  11. Karim, , Palazzo, C., Evrard, B., Piel, G. (2016). Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. Journal of Controlled Release. 227:23-37.    [Scopus indexed, Q1]
  12. Lim, Y., Koh, P.Y., Somani, S, Robaian, M., Karim, R., Yean, Y.L., Mitchell, J., Tate, R.J., Edrada-Ebel, R., Blatchford, D.R., Mullin, M.., Dufes, C. (2015). Tumor regression following intravenous administration of lactoferrin-and lactoferricin- bearing dendriplexes. Nanomedicine: Nanotechnology, Biology and Medicine. 11(6):1445-54. [Scopus indexed, Q1]
  13. Khisha, , Karim, R., Chowdhury, S. R., Banoo, R. (2012). Ethnomedical studies of chakma communities of Chittagong hill tracts, Bangladesh. Bangladesh Pharmaceutical Journal, 15(1), 59-67.
  14. Karim, R., Banoo, (2012). Review on NSAIDs: Frequently Used Drugs with Underlying Risks. Bangladesh Pharmaceutical Journal, 15(2), 187-191.
  15. Karim, R., Poly, N., Banoo, R. (2012). Development and validation of UV spectroscopic method for the determination of Metformin hydrochloride in tablet dosage form. International Journal of Pharmaceutical Sciences and Research, 3(9), 3170.

Conference Publications: (2018-Present)

  1. Karim, R., Tamanna, R., Islam, F., Islam, M.F. & Reza, H.M. (2024). Evaluation of In Vitro and Ex Vivo Permeability of Nanocapsule-Loaded Hydrogels and a Marketed Product for Transdermal Hormone Replacement Therapy. International Conference on Pharmaceutical and Health Sciences. Dhaka, Bangladesh.
  2. Fatema, R., Jahan, I., Alam, A., Islam, F., Kona, S.K., Jannat, T., Kuddus, S.A., Alam, M.A., Shohag, M.H., Karim, R., Khan, F. (2023). Cinnamic acid prevents hypercholesterolemia through down-regulating the gene expression of sterol regulatory element-binding proteins. International Conference on Pharmaceutical Sciences: Trends in 21st century, Dhaka, Bangladesh.
  3. Karim, R., Rizwan, F., Tanim, M.M.R, Khan, S.I. (2022). Comparing in vitro transmembrane permeability of a nanocarrier-hydrogel hybrid system with an alcoholic hydrogel: potential for sustained transdermal hormone 7th World Congress on Recent Advances in Nanotechnology. Lisbon, Portugal (held online due to the pandemic).
  4. Karim, R., Rizwan, F., Tanim, M.M.R, Khan, S.I. (2022). Design and evaluation of nanocarrier embedded hybrid hydrogels for topical delivery of hydrophobic 7th World Congress on Recent Advances in Nanotechnology. Lisbon, Portugal (held online due to the pandemic).
  5. Khan, S.I., Mussabbir, R., Barman, N., Islam, N., Akhter, N., Karim, R., Khan, S.I., Reza, H.M. (2022). Understanding the exponential rise of major birth defects in Bangladesh: Current treatment approaches and their outcome. The 2nd International Conference on Genomics, Nanotech, and Bioengineering-2022, Dhaka, Bangladesh.
  6. Khan, S.I., Islam, M.N., Bappy, M.J.H., Karim, R., Khan, S.I., Reza, H.M. (2022). Understanding the maternal risk factors and folate status in children with neural tube defects. The 2nd International Conference on Genomics, Nanotech, and Bioengineering-2022, Dhaka, Bangladesh.
  7. Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Eyer, J., Piel, G., & Passirani, C. (2020). Surface-functionalization of lipid nanocapsules with NFL peptide to alter their internalization into human glioblastoma cells and healthy astrocytes for targeted drug 1st Multidisciplinary International Conference on the Social and Life Sciences, Dhaka, Bangladesh.
  8. Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Eyer, J., Piel, G., & Passirani, C. (2019). Surface-functionalization with NFL peptide of Ferrocifen loaded Lipid Nanocapsules: preferential entry into human glioblastoma 9th International Symposium on Bioorganometallic Chemistry, York, United Kingdom.
  9. Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Eyer, J., Piel, G., & Passirani, C. (2018). Targeted-internalization of NFL-peptide functionalized lipid nanocapsules into human glioblastoma 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Spain.

Total conference publications: 25

For a full publication list, please refer to the Google Scholar Profile: 

https://scholar.google.be/citations?user=hpSgnCgAAAAJ&hl=en

 Fellowships

  1. Fonds Leon Fredericq Fellowship, Operational Grant 2015-2017, 2016-18.
  2. Erasmus Mundus Joint Doctorate Fellowship (NanoFar) 2014-2017
  3. Bangabandhu Fellowship on Science and ICT 2012-2013

 Research Grants

  1. CTRG Research Grant 2023-24, North South University
  2. Research project funded by Beximco & Nuvista Pharma (February 2020 - Ongoing).
  • PhD in Biomedical and Pharmaceutical Sciences, University of Liege, Belgium

      PhD in Experimental and Clinical Pharmacology, University of Angers, France (Erasmus Mundus Joint Doctorate)

  • MRes in Drug Delivery Systems, University of Strathclyde, Glasgow, United Kingdom
  • MPharm in Pharmaceutical Technology, University of Dhaka, Bangladesh
  • BPharm (Hons.), University of Dhaka, Bangladesh
  • Assistant Professor, NSU (01/2023-Present)
  • Former Assistant Professor, EWU (01/2018-01/2023)
  • Former Lecturer-Assistant Professor, SUB (2010-2017)

Product Development Officer, Novartis Bangladesh Limited (2009-2010)

Dr. Reatul Karim is actively engaged in teaching a diverse range of courses within the field of Pharmaceutical Sciences. His primary area of specialization centers on industry-oriented subjects, including:

  • Pharmaceutical Technology
  • Physical Pharmacy
  • Pharmaceutical Engineering
  • Quality Control & Quality Assurance
  • Pharmaceutical Industrial Management
  • Statistics
  • Pharmaceutical Biotechnology
  • Molecular Diagnostics
  • European Society for Nanomedicine (ESNAM)
  • Controlled Release Society, Indian Chapter (CRSIC)
  • Erasmus Mundus Student and Alumni Association
  • Nanocarrier development
  • Drug delivery
  • Public health